Weiting Kang
7PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 18, 2025
Targeting the SMAD3/CISD2 axis suppresses bladder cancer progression by promoting ferroptosis in mesenchymal-like bladder cancer cells.Yulin Sun, Jianghui Wang, Da Gu
|Dec 24, 2021
Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis".Chenglin Han, Zilong Wang, Shuxiao Chen
|Aug 06, 2021
Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.Hui Xiong, Hui Gao, Jinding Hu
|Mar 17, 2021
Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications.Qiang Wang, Jinding Hu, Weiting Kang
|Feb 01, 2021
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis.Chenglin Han, Zilong Wang, Shuxiao Chen
|Dec 31, 2020
Corrigendum to "The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma".Weiting Kang, Meng Zhang, Qiang Wang
Pageof 2
Frequent Collaborators
4 joint publications
Zilian Cui
3 joint publications
Da Gu
3 joint publications
Hanbo Wang
3 joint publications
Qinghua Xia
3 joint publications
Xunbo Jin
2 joint publications
Meng Zhang
2 joint publications
Qiang Wang
2 joint publications
Zhilong Huang
2 joint publications
Yuzhu Xiang
2 joint publications
Chenglin Han
